drugset / Trial / NCT01581450

Hyperalgesia and Pain

NCT01581450

Phase 1 Completed 20 enrolled Air Liquide ORION Clinical Services · collab
RandomizedCrossoverDouble-blindTreatment

Summary

Evaluation of the effects of 35%/15%/50% N2O/N2/O2 mixtures on the area of hyperalgesia induced by remifentanil in the CCES (Continuous Cutaneous Electrical Stimulation) model in 20 healthy volunteers. The duration of participation for each volunteer is expected to be around 9 weeks with the performance of 4 experimental session 2 weeks apart. The selection visit will last half a day; each experimental session will last half a day; the study end will last 2 hours maximum.

Timeline

Start
2012-01
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitrous Oxide Other / unclassified 35 % Inhaled
Comparator Nitrous Oxide Other / unclassified 50 % Inhaled

Indications

No indication recorded.